These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2902130)

  • 41. Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.
    Dunkley ML; Rajyaguru S; McCue A; Cripps AW; Kyd JM
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):37-44. PubMed ID: 14556994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia.
    Zweerink HJ; Detolla LJ; Gammon MC; Hutchison CF; Puckett JM; Sigal NH
    J Infect Dis; 1990 Jul; 162(1):254-7. PubMed ID: 2113078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia.
    Kapusnik JE; Hackbarth CJ; Chambers HF; Carpenter T; Sande MA
    J Infect Dis; 1988 Jul; 158(1):7-12. PubMed ID: 3392422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis.
    Louie A; Liu W; Liu QF; Sucke AC; Miller DA; Battles A; Miller MH
    Lab Anim Sci; 1997 Dec; 47(6):617-23. PubMed ID: 9433698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory T cell activity in immunosuppresive mice model of pseudomonas aeruginosa pneumonia.
    Li JL; Chen TS; Yuan CC; Zhao GQ; Xu M; Li XY; Cao J; Xing LH
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):505-509. PubMed ID: 28786066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody.
    Hector RF; Collins MS; Pennington JE
    J Infect Dis; 1989 Sep; 160(3):483-9. PubMed ID: 2760499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K; Wiener-Kronish JP; Sawa T
    Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipopolysaccharide pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa.
    Pennington JE
    J Infect Dis; 1979 Jul; 140(1):73-80. PubMed ID: 110888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and patient acceptability of intravenous immune globulin in 10% maltose.
    Ochs HD; Buckley RH; Pirofsky B; Fischer SH; Rousell RH; Anderson CJ; Wedgwood RJ
    Lancet; 1980 Nov; 2(8205):1158-9. PubMed ID: 6107768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
    Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
    J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression.
    Pennington JE; Ehrie MG
    J Infect Dis; 1978 Jun; 137(6):764-74. PubMed ID: 96188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia.
    Dale DC; Reynolds HY; Pennington JE; Elin RJ; Pitts TW; Graw RG
    J Clin Invest; 1974 Sep; 54(3):664-71. PubMed ID: 4212040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model.
    Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
    J Cyst Fibros; 2016 Mar; 15(2):171-8. PubMed ID: 26303991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Alterations of pulmonary surfactant during Pseudomonas aeruginosa pneumonia of immunocompromised rats].
    Li Z; Qu J; He L
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):204-7. PubMed ID: 11802963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experiences with a Pseudomonas immunoglobulin in ventilated patients with Pseudomonas pneumonia in a surgical intensive care station].
    Böhm D
    Infection; 1987; 15 Suppl 2():S64-6. PubMed ID: 3112023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
    Infection; 1987; 15(1):60-8. PubMed ID: 3570485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.